Description: China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd.
Home Page: www.shineway.com
No. 168, Shiluan Street
Shijiazhuang,
051430
China
Phone:
86 31 1880 30066
Officers
| Name | Title |
|---|---|
| Mr. Zhenjiang Li | Co-Founder & Executive Chairman |
| Ms. Yunxia Xin | Co-Founder & Executive Director |
| Mr. Huimin Li | Executive Director |
| Mr. Bun Ching Lee | Financial Controller & Company Secretary |
| Mr. King Kuen Hung AICPA, HKICPA, MBA | Director of Investor Relation |
| Mr. Yudong Zhang | General Manager of Sales & Marketing |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 6 |
| Price-to-Book MRQ: | 0.9022 |
| Price-to-Sales TTM: | 0.2158 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3232 |